» Articles » PMID: 29118767

Long-Term Progression of Coronary Artery Calcification Is Independent of Classical Risk Factors, C-Reactive Protein, and Parathyroid Hormone in Renal Transplant Patients

Overview
Journal Cardiorenal Med
Publisher Karger
Date 2017 Nov 10
PMID 29118767
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Compared to the general population, mortality is significantly increased in renal transplant recipients. In the general population, coronary artery calcification (CAC) and its evolution over time are associated with cardiovascular and all-cause mortality, and the study of this biomarker could provide useful information for describing the long-term progression of coronary heart disease in renal transplant recipients.

Methods: We followed up a cohort of 113 renal transplant patients by performing three multi-detector computed tomography studies over 83.6 ± 6.8 months. Data analysis was performed by logistic regression analysis and by mixed linear modelling.

Results: Progression was observed in 34.5% of patients. Baseline CAC and time-to-transplantation were the sole variables that predicted CAC evolution over time. Neither classical nor nontraditional risk factors, biomarkers of renal function (GFR) and kidney damage (albuminuria) or biomarkers of bone mineral disorder (BMD), such as serum phosphorus, calcium, and PTH, were associated with the long-term progression of coronary calcification. Serum triglycerides predicted CAC progression only in logistic regression analysis, while in addition to baseline CAC, time to transplantation was the sole variable predicting CAC progression when the data were analyzed by mixed linear modelling. These data suggested that, in addition to the background calcification burden, other unmeasured factors play major roles in promoting the evolution of coronary calcification in the transplant population.

Conclusion: CAC progression continued over the long-term follow-up of renal transplant patients. This phenomenon was unaccounted for by classical and nontraditional risk factors, as well as by biomarkers of renal dysfunction and renal damage.

Citing Articles

Vascular calcification progression and its association with mineral and bone disorder in kidney transplant recipients.

Sun L, Huang Z, Fei S, Ni B, Wang Z, Chen H Ren Fail. 2023; 45(2):2276382.

PMID: 37936391 PMC: 10653689. DOI: 10.1080/0886022X.2023.2276382.


Vitamin K1 and K2 in the Diet of Patients in the Long Term after Kidney Transplantation.

Kluch M, Bednarkiewicz P, Orzechowska M, Grzelak P, Kurnatowska I Nutrients. 2022; 14(23).

PMID: 36501100 PMC: 9741316. DOI: 10.3390/nu14235070.


Coronary artery calcification progression and long-term cardiovascular outcomes in renal transplant recipients: an analysis by the joint model.

Seyahi N, Alagoz S, Atli Z, Ozcan S, Tripepi G, Bakir A Clin Kidney J. 2022; 15(1):101-108.

PMID: 35106150 PMC: 8796795. DOI: 10.1093/ckj/sfab174.


Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees.

Rapp N, Evenepoel P, Stenvinkel P, Schurgers L Toxins (Basel). 2020; 12(10).

PMID: 33003628 PMC: 7599869. DOI: 10.3390/toxins12100624.


Alteration of serum immunoglobins, C-reactive protein, vitamin D, and electrolyte by atenolol and amlodipine in stress-induced hypertensive rats.

Hejazi M, Bacha A, Kaleemuddin M, Al-Abassi F, Al-Alsieni A, Kazmi I Mol Cell Biochem. 2017; 445(1-2):99-103.

PMID: 29248973 DOI: 10.1007/s11010-017-3255-y.

References
1.
Min J, Lin F, Gidseg D, Weinsaft J, Berman D, Shaw L . Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the "warranty period" for remaining normal?. J Am Coll Cardiol. 2010; 55(11):1110-7. DOI: 10.1016/j.jacc.2009.08.088. View

2.
McEvoy J, Blaha M, DeFilippis A, Budoff M, Nasir K, Blumenthal R . Coronary artery calcium progression: an important clinical measurement? A review of published reports. J Am Coll Cardiol. 2010; 56(20):1613-22. DOI: 10.1016/j.jacc.2010.06.038. View

3.
Ojo A, Morales J, Gonzalez-Molina M, Steffick D, Luan F, Merion R . Comparison of the long-term outcomes of kidney transplantation: USA versus Spain. Nephrol Dial Transplant. 2012; 28(1):213-20. PMC: 3616762. DOI: 10.1093/ndt/gfs287. View

4.
Baia L, Humalda J, Vervloet M, Navis G, Bakker S, de Borst M . Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation. Clin J Am Soc Nephrol. 2013; 8(11):1968-78. PMC: 3817902. DOI: 10.2215/CJN.01880213. View

5.
Yilmaz M, Sonmez A, Saglam M, Cayci T, Kilic S, Unal H . A longitudinal study of inflammation, CKD-mineral bone disorder, and carotid atherosclerosis after renal transplantation. Clin J Am Soc Nephrol. 2014; 10(3):471-9. PMC: 4348690. DOI: 10.2215/CJN.07860814. View